今开:5.41 | 昨收:5.44 |
最高:5.5299 | 最低:5.26 |
涨停价:0.0 | 跌停价:0.0 |
总市值:2.8014424E7 |
产业链观察03-28 23:40
#药闻简讯# 2024年3月28日-- 生物制药公司$Lipocine(LPCN)$ 今天宣布LPCN 1148的2期临床研究取得了积极的顶线结果。LPCN 1148是一种正在开发的口服候选药物,用于肝硬化的临床管理,特别是预防OHE复发和治疗肌肉减少症。LPCN 1148的目标是成为具有新作用机制(MOA)的“同类首创”候选产品。Lipoci...查看全文
爆炒用户01-18 11:21
$Lipocine(LPCN)$ 本周美股可以关注LPCN 制药板块技术上底部低位突破反弹量能开始慢慢介入资金, 技术指标KDJ MACD金叉。 买入支撑在3.8-3.5附近,现价3.85,今日找介入机会,目标5查看全文
Lipocine(LPCN)04-11 19:35
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-014273 Act: 34 Size: 6 MB 网页链接查看全文
Lipocine(LPCN)03-28 18:35
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-011600 Act: 34 Size: 290 KB 网页链接查看全文
Lipocine(LPCN)03-25 18:25
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-011053 Act: 34 Size: 261 KB 网页链接查看全文
Lipocine(LPCN)03-07 19:15
$Lipocine(LPCN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-24-009127 Act: 34 Size: 9 MB 网页链接查看全文
Lipocine(LPCN)03-08 06:35
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-009283 Act: 34 Size: 14 MB 网页链接查看全文
Lipocine(LPCN)03-07 19:15
$Lipocine(LPCN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-24-009128 Act: 34 Size: 406 KB 网页链接查看全文
Lipocine(LPCN)03-13 05:55
$Lipocine(LPCN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-009707 Size: 4 KB 网页链接查看全文
Lipocine(LPCN)03-13 05:55
$Lipocine(LPCN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-009705 Size: 4 KB 网页链接查看全文
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-014273 Act: 34 Size: 6 MB 网页链接
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-011600 Act: 34 Size: 290 KB 网页链接
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-011053 Act: 34 Size: 261 KB 网页链接
$Lipocine(LPCN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-009705 Size: 4 KB 网页链接
$Lipocine(LPCN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-009707 Size: 4 KB 网页链接
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-009283 Act: 34 Size: 14 MB 网页链接
$Lipocine(LPCN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-24-009127 Act: 34 Size: 9 MB 网页链接
$Lipocine(LPCN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-24-009128 Act: 34 Size: 406 KB 网页链接
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-008925 Act: 34 Size: 256 KB 网页链接
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-005897 Act: 34 Size: 256 KB 网页链接